Clinical Trial Update: Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy [Phase 2]

View source ↗

Summary

Phase 2 trial of Revatio (sildenafil) for Duchenne and Becker muscular dystrophy was terminated; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Becker Muscular Dystrophy
• Duchenne Muscular Dystrophy

Drugs mentioned

• REVATIO (SILDENAFIL CITRATE)

Snippet

Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Conditions: Duchenne Muscular Dystrophy, Becker Muscular Dystrophy | Phase 2 | Status: TERMINATED | Results posted: 2018-03-21